SCNX Scienture Holdings, Inc.

2.435USD-4.51%Mkt Cap: 4.35M USDP/E: —

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The …

Institutional holders15 on file

Key Statistics

Company
Market Cap4.35M USD
Enterprise Value7.41M USD
Revenue (TTM)821.32K USD
Gross Profit331.48K USD
Net Income (TTM)-41.51M USD
Revenue/Share0.70 USD
Last Price2.435 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees4
CountryUS
SectorHealthcare
IndustryPharmaceutical Retailers
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.70
PEG—
EV/EBITDA-0.60
EV/Revenue9.03
P/S5.30
P/B0.06
EPS (TTM)-52.75 USD
EPS (Forward)-0.27 USD
52W Range
2.2401% of range19.48
52W High19.48 USD
52W Low2.240 USD
Profitability
Gross Margin76.80%
Oper. Margin-1671.08%
EBITDA Margin0.00%
Profit Margin-9618.03%
ROE-59.20%
ROA-49.31%
ROIC-24.42%
ROCE-19.95%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.38M USD
CapEx (TTM)—
FCF Margin-926.74%
FCF Yield-174.83%
Net Debt2.50M USD
Net Debt/EBITDA-0.20
Net Debt/FCF—
Balance Sheet
Debt/Equity0.00
Current Ratio3.04
Quick Ratio2.83
Book Value/Sh43.15 USD
Cash/Share4.99 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJul 19, 2024
Pay DateJul 24, 2024
Splits
Last Split1:25
Split DateOct 5, 2026
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)6.000 USD
Upside (mean)+146.4%
Target Range6.000 USD – 6.000 USD
# Analysts1
Ownership
Shares Out.1.79M
Float1.28M
Insiders22.25%
Institutions4.92%
Short Interest
Short Ratio0.3d
Short % Float8.88%
Short % Out.7.14%
Shares Short117.35K
Short (prev mo.)52.17K
Technical
SMA 504.857 (-49.9%)
SMA 2008.672 (-71.9%)
Beta4.31
S&P 52W Chg12.08%
Avg Vol (30d)46.02K
Avg Vol (10d)19.88K
Technical Indicators
RSI (14)26.3
MACD-0.4831
MACD Signal-0.5411
MACD Hist.+0.0580
BB Upper3.634 USD
BB Middle3.070 USD
BB Lower2.506 USD
BB Width36.77%
ATR (14)0.3704 USD
Vol Ratio (20d)1.32x

About Scienture Holdings (NASDAQ: SCNX)

›

Scienture Holdings (NASDAQ: SCNX) is listed on Nasdaq, where its shares trade in USD. It belongs to the Pharmaceutical Retailers industry, part of the Healthcare sector, and reports about 4 employees.

The shares were at 2.435 USD on 19 November 2026, down 87.6% over 52 weeks. Its 52-week range is 2.240 USD to 19.48 USD: the price is 87.5% below the high and 8.7% above the low.

Its market capitalisation is 4.35M USD.

Scienture Holdings reports return on equity of -59.2%.

Its debt exceeds its cash by 2.50M USD, a debt-to-equity ratio of 0.00. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. One analyst covers the stock, with an average rating of Buy; their mean price target of 6.000 USD is 146.4% above the current price.